View this email in your browser
September 16, 2018
  • In 2017, rising sales of concentrates in Colorado represented nearly 30% of all retail cannabis sales.
  • While in Q1-2016 sales of medical concentrates were 44% higher than for adult-use sales, preferences had flipped by Q4-2017 as adult-use sales outpaced medical sales by 6%.
  • Overall, the number of concentrates sold per adult cannabis consumer in the state grew more than 58%, from 10.4 grams per person per year in 2016 to 16.5 grams in 2017. 
  • Surging demand for concentrates significantly impacts the cannabis supply chain. Some growers are establishing specific cultivation facilities for flower extraction
  • Sales of concentrates are spurring dramatic parallel growth in sales of vape hardware and dab rigs (oil consumption devices). 
  • Colorado offers an indication of the demand trajectory for concentrates as adult use markets expand nationally.
  • Consumers in the illicit market prefer flower, access to concentrate products quickly shifts their preferences, with concentrates and accessories becoming increasingly popular among their shopping carts.

The CBD Report: 2018 Industry Outlook

The CBD Report is the leading authority on market sizes and analysis of business trends on the CBD (cannabidiol) industry. 

This report is Hemp Business Journal’s third annual report and its first publication as a division of New Frontier Data. It is the definitive report on the U.S. CBD market, featuring over 100 pages of primary research, market analytics, investment intelligence, and insights from trusted industry leaders.​
  • 100+ pages of Market Intel, Data & Analysis
  • 45+ NEW Data Charts never before published
  • CBD product retail sales in dispensaries ("Marijuana-Derived") and all other retail channels ("Hemp-Derived")
  • Company sales leaders across hemp-derived CBD and marijuana-derived CBD markets
  • Market Forces: Analysis, Insights and Forecasting on GW Pharmaceuticals,  Greenwhich Biosciences, Epidiolex, FDA, DEA
  • Latest Medical Findings and Research
  • Extensive coverage on the latest trends and innovations in the Natural and Specialty Market
  • M&A Activity and Canada market insights
  • Updated HJB Power Rankings for Hemp-Derived CBD companies
  • And more!
Get it Today!
You Asked, We Answered
How is interstate commerce of cannabis restricted under current laws and how would that be affected by federal legalization?
Currently, interstate commerce of cannabis is illegal under federal law. All state-legal production, supply and sales are allowed, so long as they remain within that state’s borders. The federal government is increasingly involving itself in issues of out-of-state export, aka leakage... Read our full answer here
Ask Our Experts is a new weekly interactive feature in the CannaBit.

Recognizing Banking Risks in Emerging Cannabis Business Ventures

By Zoe Grimaldi and ​J. J. McCoy, New Frontier Data
In 2014, Sundie Seefried founded Safe Harbor Services, the nation’s first federally compliant cannabis banking program. Safe Harbor enables financial institutions to extend business banking solutions to cannabis-related businesses (CRBs). Nearly five years later, Seefried, now the CEO of Partner Colorado Credit Union (owner of Safe Harbor), still surveys the excitement of the green rush, and optimism about the market, cautiously....
Read Here

Some reinventing the cannabis tax-reform wheel as they go along


By Tracy Curley, Partner at Cohnreznick

The legal status of cannabis presents a challenge toward advancements in quality assurance and medical research. Currently, the Controlled Substance Act carries no distinction between the medical and recreational uses of cannabis, which is classified as a Schedule I drug – meaning a substance or chemical defined by the federal government as a drug with no currently accepted medical use and a high potential for abuse...

Read Here

U.S. Investment Opportunity Ranking! 

This new Investment Opportunity Ranking tool is a composite index that considers opportunities and risks across a number of different market segments on a quarterly basis, as part of Equio’s continued focus on risk and investments tools for all cannabis industry stakeholders:

  • Cultivation
  • Retail
  • Manufacturing
  • Distribution
  • Ancillary services 
Start Your Free Equio Trial Today!
New Frontier Data CBD Market Projections Quoted...

Cannabidiol industry growing in Massachusetts

Tired of having to take what she described as a “pharmaceutical cocktail,” Beverly Barish in 2012 decided to seek an alternative remedy to treat her fibromyalgia and migraines...

Read the full article here >

Why The Adult Cannabis Market Could Kill Its Medical Counterpart

Read the full article here >

Denver mayor unveils 2019 proposed budget, outlines priorities

Read the full article here >

Here’s why marijuana use is on the rise among older adults, study finds

Read the full article here >

Survey: Majority of Michigan officials oppose medical marijuana facilities

Read the full article here >
Copyright © 2018 Frontier Financial Group, Inc., dba New Frontier Data, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.